• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇科细胞病理学与对完美的追求:民事责任及监管影响

Gynaecological cytopathology and the search for perfection: civil liability and regulatory ramifications.

作者信息

Freckelton Ian

机构信息

Owen Dixon Chambers, C/- Clerk Howells, 205 William St, Melbourne, Vic 3000, Australia.

出版信息

J Law Med. 2003 Nov;11(2):185-200.

PMID:14655583
Abstract

The article analyses the potential for false negative and false positive results from Pap smear testing by gynaecological cytopathology laboratories. It also reviews case law in relation to the liability of general practitioners, gynaecologists, cytoscreeners and pathologists in respect of cervical cancer diagnoses. It argues that the concerns expressed in the 1990s about unfair findings of liability against cervical screeners have not been borne out, liability only having been found by the courts where culpable failure to adhere to the standards to be expected of professional behaviour has been established by probative evidence. It argues that the challenge for the future is for cytology screening to articulate definitively where the distinctions lie between acceptable and unacceptable error and for the medical profession and the legal profession to accommodate to the limitations of gynaecological cytopathology.

摘要

本文分析了妇科细胞病理学实验室进行巴氏涂片检测时出现假阴性和假阳性结果的可能性。它还回顾了与全科医生、妇科医生、细胞筛查人员和病理学家在宫颈癌诊断方面的责任相关的判例法。文章认为,20世纪90年代对宫颈筛查人员责任认定不公平的担忧并未得到证实,只有在通过确凿证据证明存在应受谴责的未能遵守专业行为预期标准的情况下,法院才会判定责任。文章认为,未来的挑战在于细胞学筛查要明确界定可接受误差和不可接受误差之间的区别,以及医学专业和法律专业要适应妇科细胞病理学的局限性。

相似文献

1
Gynaecological cytopathology and the search for perfection: civil liability and regulatory ramifications.妇科细胞病理学与对完美的追求:民事责任及监管影响
J Law Med. 2003 Nov;11(2):185-200.
2
Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.法医学事务。国际细胞学会特别工作组总结。《迈向21世纪的诊断细胞学:一次国际专家会议及教程》
Acta Cytol. 1998 Jan-Feb;42(1):76-119; discussion 120-32. doi: 10.1159/000331537.
3
The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.妇科医生对巴氏涂片检查的责任及质量问题的看法。
Arch Pathol Lab Med. 1997 Mar;121(3):246-9.
4
The evolution of the Papanicolaou smear.帕潘尼古拉乌涂片检查法的发展历程。
Clin Obstet Gynecol. 2013 Mar;56(1):3-9. doi: 10.1097/GRF.0b013e318282b982.
5
Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears.巴氏涂片的质量与责任问题:错误及假阴性涂片的定义问题
Arch Pathol Lab Med. 1997 Mar;121(3):267-9.
6
ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.采用薄层液基细胞学检测减少宫颈细胞学假阴性结果。
Arch Pathol Lab Med. 1998 Feb;122(2):139-44.
7
Regulatory closure of cervical cytology laboratories: recommendations for a public health response.宫颈细胞学实验室的监管关闭:公共卫生应对建议。
MMWR Recomm Rep. 1997 Dec 19;46(RR-17):1-19.
8
Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.巴氏涂片检查:我们能否让一项良好的检查变得更好?从业者面临的技术与解读挑战
J Womens Health Gend Based Med. 1999 May;8(4):469-76. doi: 10.1089/jwh.1.1999.8.469.
9
[Sampling devices for the Papanicolaou test].
Minerva Ginecol. 1992 Sep;44(9):441-7.
10
False-Negative Rate of Papanicolaou Testing: A National Survey from the Thai Society of Cytology.巴氏涂片检查的假阴性率:泰国细胞学协会的全国性调查。
Acta Cytol. 2017;61(6):434-440. doi: 10.1159/000478770. Epub 2017 Jul 25.